Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells

Prostate

Volumn 72, Issue 1, 2012, Pages 40-50

  Rodríguez Berriguete, Gonzalo ^a   Fraile, Benito ^a   Paniagua, Ricardo ^a   Aller, Patricio ^b   Royuela, Mar ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

apoptosis; NF kappaB; prostate cancer; TNF alpha

Indexed keywords

CASPASE 3; CASPASE 8; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL STRAIN LNCAP; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; APOPTOSIS; ENZYME INHIBITORS; HUMANS; I-KAPPA B KINASE; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81855185609     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21404     Document Type: Article

References (27)

1. Brouckaert PGG, Leroux-Roels GG, Guisez Y, Tavernier J, Fiers W,. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma on a syngeneic murine melanoma. Int J Cancer 1986; 38: 763-769.
2. Balkwill FR, Proietti E,. Effects of mouse interferon on human tumour xenografts in the nude mouse host. Int J Cancer 1986; 38 (3): 375-380.
3. Talmadge JE,. Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res 1988; 48: 544-550.
4. Sherwood ER, Pitt Ford TR, Lee C, Kozlowski JM,. Therapeutic efficacy of recombinant tumor necrosis factor alpha in an experimental model of human prostatic carcinoma. J Biol Response Mod 1990; 9 (1): 44-52.
5. Balkwill F,. Tumour necrosis factor and cancer. Nat Rev Cancer 2009; 9 (5): 361-371.
6. Wheelhouse NM, Chan YS, Gillies SE, Caldwell H, Ross JA, Harrison DJ, Prost S,. TNF-alpha induced DNA damage in primary murine hepatocytes. Int J Mol Med 2003; 12 (6): 889-894.
7. Iocca HA, Isom HC,. Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. Am J Pathol 2003; 163 (2): 465-476.
8. Balkwill F,. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 2006; 25 (3): 409-416.
9. Srinivasan S, Kumar R, Koduru S, Chandramouli A, Damodaran C,. Inhibiting TNF-mediated signaling: A novel therapeutic paradigm for androgen independent prostate cancer. Apoptosis 2010; 15 (2): 153-161.
10. Karin M,. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441 (7092): 431-436.
11. Kato T Jr, Delhase M, Hoffmann A, Karin M,. CK2 is a C-terminal IkappaB kinase responsible for NF-kappaB activation during the UV response. Mol Cell 2003; 12 (4): 829-839.
12. Baeza-Raja B, Munoz-Canoves P,. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: Role of interleukin-6. Mol Biol Cell 2004; 15 (4): 2013-2026.
13. Kim HJ, Lee HS, Chong YH, Kang JL,. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 2006; 225 (1): 36-47.
14. Festjens N, Cornelis S, Lamkanfi M, Vandenabeele P,. Caspase-containing complexes in the regulation of cell death and inflammation. Biol Chem 2006; 387 (8): 1005-1016.
15. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P,. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007; 14 (3): 400-410.
16. de Miguel MP, Royuela M, Bethencourt FR, Santamaria L, Fraile B, Paniagua R,. Immunoexpression of tumour necrosis factor-alpha and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostate. Cytokine 2000; 12 (5): 535-538.
17. Bouraoui Y, Ricote M, Garcia-Tunon I, Rodriguez-Berriguete G, Touffehi M, Rais NB, Fraile B, Paniagua R, Oueslati R, Royuela M,. Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer. Cancer Detect Prev 2008; 32 (1): 23-32.
18. Michalaki V, Syrigos K, Charles P, Waxman J,. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 2004; 90 (12): 2312-2316.
19. Ricote M, Garcia-Tunon I, Bethencourt F, Fraile B, Onsurbe P, Paniagua R, Royuela M,. The p38 transduction pathway in prostatic neoplasia. J Pathol 2006; 208 (3): 401-407.
20. Schreiber E, Matthias P, Muller MM, Schaffner W,. Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J 1988; 7 (13): 4221-4229.
21. Ramos AM, Fernandez C, Amran D, Esteban D, de Blas E, Palacios MA, Aller P,. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. J Cell Physiol 2006; 209 (3): 1006-1015.
22. Shukla S, MacLennan GT, Fu P, Patel J, Marengo SR, Resnick MI, Gupta S,. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 2004; 6 (4): 390-400.
23. Royuela M, De Miguel MP, Bethencourt FR, Fraile B, Arenas MI, Paniagua R,. IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: Immunohistochemical comparative analysis. Growth Factors 2000; 18 (2): 135-146.
24. Rodriguez-Berriguete G, Fraile B, de Bethencourt FR, Prieto-Folgado A, Bartolome N, Nunez C, Prati B, Martinez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M,. Role of IAPs in prostate cancer progression: Immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate. BMC Cancer 2010; 10: 18.
25. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H, Kobayashi R, Hung MC,. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004; 117 (2): 225-237.
26. Gringhuis SI, Garcia-Vallejo JJ, van Het Hof B, van Dijk W,. Convergent actions of I kappa B kinase beta and protein kinase C delta modulate mRNA stability through phosphorylation of 14-3-3 beta complexed with tristetraprolin. Mol Cell Biol 2005; 25 (15): 6454-6463.
27. Lee DF,. IKKB suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007; 130: 440-455.